7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 
      
    		                                   
      cash flows from operating activities
    		                                   
      net income
    		-5,212,000 -14,218,000 -30,700,000 -1,333,000 -46,182,000 -20,107,000 -45,667,000 -38,699,000 -27,116,000 -18,482,000 -39,109,000 -21,451,000 -23,897,000 -50,609,000 -32,491,000 -23,731,000 -17,360,000 -27,779,000 -9,651,000 -4,677,000 -20,437,000 -9,065,000 -17,300,000 -17,782,000 -11,467,000 -8,019,000 -14,713,000 -10,244,000 -12,206,000 -11,117,000 -11,149,000 -6,524,000 -6,444,000 -5,303,000 -6,266,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                   
      depreciation and amortization
    		5,173,000 5,105,000 5,210,000 5,289,000 5,135,000 5,160,000 5,131,000 4,914,000 4,067,000 3,791,000 3,576,000 3,436,000 3,351,000 3,143,000 3,104,000 2,549,000 2,153,000 2,036,000 1,978,000 1,702,000 1,669,000 1,551,000 1,188,000 965,000 671,000 621,000 596,000 568,000 557,000 548,000 494,000 468,000 337,000 298,000 -78,000 
      stock-based compensation
    		21,006,000 22,827,000 23,344,000 16,008,000 17,158,000 21,821,000 20,991,000 23,846,000 21,008,000 14,099,000 18,251,000 12,945,000 15,098,000 13,903,000 11,876,000 12,161,000 10,260,000 20,230,000 13,998,000 17,444,000 9,768,000 305,000 7,177,000 7,319,000 7,330,000 4,415,000 4,795,000 4,211,000 4,076,000 3,247,000 3,099,000 2,732,000 2,264,000 2,028,000 620,000 
      amortization of premium and accretion of discounts
    		-892,000 -654,000 -619,000 -114,000 -87,000 -241,000 -908,000 -1,413,000 -1,416,000                           
      amortization of operating lease right-of-use assets
    		1,448,000 1,423,000 1,393,000 1,315,000 1,263,000 1,240,000 1,244,000 1,553,000 1,494,000 1,384,000 1,365,000 -2,998,000 1,316,000 6,547,000  1,814,000 1,672,000 1,555,000  1,511,000 1,491,000 1,495,000  2,391,000 3,878,000 1,183,000          
      amortization of debt discount
    		746,000 770,000 794,000 623,000 843,000 752,000 578,000                             
      change in fair value of strategic investments
    		-894,000 -2,152,000 -843,000 -843,000                                
      benefit from credit losses and contractual allowances
    		25,457,000 25,277,000 29,427,000 20,726,000 17,251,000                               
      acquired in-process research and development
    		302,000 1,698,000 296,000 302,000                                
      loss on extinguishment of debt
    		   0 0 0 7,589,000                             
      impairment charges
    		0   0        0 0 23,164,000                      
      other
    		790,000 69,000 103,000 215,000 -179,000 290,000 106,000 703,000 -507,000 -35,000 176,000 3,000                        
      changes in operating assets and liabilities:
    		                                   
      accounts receivable
    		-19,461,000 -26,791,000 -30,125,000 -23,240,000 -9,164,000 -14,998,000 -44,518,000 -29,389,000 -13,128,000 -17,612,000 -21,064,000 -17,683,000 -17,321,000 -22,878,000 -6,749,000 848,000 -7,853,000 -39,818,000 -11,957,000 -13,006,000 -3,005,000 -9,989,000 -5,930,000 -4,951,000 -6,860,000 -10,984,000 -7,797,000 -3,891,000 -5,661,000 -5,536,000 -4,390,000 -2,898,000 -2,314,000 -3,348,000 -1,400,000 
      inventory
    		-1,849,000 -4,213,000 -388,000 817,000 425,000 -543,000 -923,000 -906,000 1,340,000 1,949,000 -1,404,000 -29,000 -1,969,000 -2,377,000 -317,000 -616,000 -2,419,000 -1,608,000 -330,000 -44,000 -824,000 -191,000 -538,000 -724,000 -270,000 -442,000 257,000 -152,000 -311,000 -174,000 -369,000 -83,000 -75,000 234,000 282,000 
      prepaid expenses and other current assets
    		-1,276,000 2,624,000 -4,165,000 -2,860,000 1,687,000 -1,335,000 7,813,000 -9,487,000 -289,000 -207,000 -1,053,000 1,200,000 1,313,000 -146,000 -4,051,000 1,577,000 -242,000 387,000 -2,680,000 -939,000 478,000 114,000 -684,000 15,000 142,000 -169,000 -1,337,000 -277,000 -744,000 790,000 -598,000 -172,000 -428,000 403,000 -658,000 
      other assets
    		-3,708,000 -446,000 729,000 3,835,000 4,392,000 -312,000 -4,694,000 -991,000 -8,325,000 -10,282,000 -3,189,000 -9,000 -1,032,000 -3,058,000 -1,358,000 -444,000 746,000 -775,000 -2,711,000 -710,000 -726,000 -2,002,000 -2,366,000 -1,192,000 -809,000 -365,000 -50,000 -306,000 216,000 409,000 326,000 -285,000 -162,000 -346,000 -393,000 
      accounts payable and accrued liabilities
    		15,007,000 15,171,000 -489,000 971,000 2,302,000 2,196,000 -12,877,000                             
      deferred revenue
    		725,000 217,000 350,000 -99,000 -115,000 78,000 -238,000 -77,000 -312,000 209,000 435,000 27,000 43,000 -116,000 675,000 -133,000 1,082,000 495,000 -8,000 -259,000 82,000 -136,000 362,000 -289,000 -111,000 66,000 69,000 532,000 -457,000 -139,000 334,000 347,000 -423,000 33,000 97,000 
      operating lease liabilities
    		-2,479,000 -1,527,000 -2,208,000 -2,380,000 -2,033,000 -1,358,000 -1,945,000 -1,797,000 -2,031,000 -1,702,000 -59,000 3,081,000 -1,598,000 -6,175,000 1,223,000 1,617,000 -1,212,000 -1,364,000 -1,284,000 -1,209,000 -1,163,000 -1,163,000 -1,162,000 -355,000 -2,524,000 -1,200,000          
      net cash from operating activities
    		34,883,000 27,659,000 -7,891,000 19,232,000 24,347,000 11,840,000 -52,029,000 -15,972,000 1,196,000 -4,572,000 -30,753,000 3,669,000 -372,000 -38,885,000 -13,045,000 17,677,000 -543,000 -41,842,000 7,818,000 10,942,000 -10,153,000 -22,366,000 -4,860,000 -222,000 318,000 -17,099,000 -4,348,000 -5,097,000 -6,363,000 -13,260,000 -3,723,000 -3,788,000 -1,001,000 -6,399,000 -1,034,000 
      capex
    		-14,831,000 -10,369,000 -9,419,000 -6,844,000 -8,834,000 -8,488,000 -9,776,000 -13,517,000 -9,087,000 -9,397,000 -8,423,000 -6,333,000 -10,832,000 -5,572,000 -4,625,000 -13,308,000 -5,923,000 -4,211,000 -2,364,000 -5,601,000 -2,181,000 -3,405,000 -11,817,000 -4,172,000 -2,833,000 -1,635,000 -1,493,000 -1,461,000 -1,118,000 -1,108,000 -911,000 -531,000 -946,000 -1,174,000 -942,000 
      free cash flows
    		20,052,000 17,290,000 -17,310,000 12,388,000 15,513,000 3,352,000 -61,805,000 -29,489,000 -7,891,000 -13,969,000 -39,176,000 -2,664,000 -11,204,000 -44,457,000 -17,670,000 4,369,000 -6,466,000 -46,053,000 5,454,000 5,341,000 -12,334,000 -25,771,000 -16,677,000 -4,394,000 -2,515,000 -18,734,000 -5,841,000 -6,558,000 -7,481,000 -14,368,000 -4,634,000 -4,319,000 -1,947,000 -7,573,000 -1,976,000 
      cash flows from investing activities
    		                                   
      purchases of property and equipment
    		-14,831,000 -10,369,000 -9,419,000 -6,844,000 -8,834,000 -8,488,000 -9,776,000 -13,517,000 -9,087,000 -9,397,000 -8,423,000 -6,333,000 -10,832,000 -5,572,000 -4,625,000 -13,308,000 -5,923,000 -4,211,000 -2,364,000 -5,601,000 -2,181,000 -3,405,000 -11,817,000 -4,172,000 -2,833,000 -1,635,000 -1,493,000 -1,461,000 -1,118,000 -1,108,000 -911,000 -531,000 -946,000 -1,174,000 -942,000 
      purchases of marketable securities
    		-171,073,000 -135,146,000 -34,320,000 -115,815,000 0 0 -2,426,000 -55,083,000 -36,351,000                           
      maturities of marketable securities
    		99,000,000 44,600,000 5,600,000 2,500,000 8,500,000 38,000,000 52,200,000 70,000,000 30,000,000                           
      purchases of strategic investments
    		   -2,000,000 -40,000,000                               
      purchases of acquired in-process research and development
    		                                   
      net cash from investing activities
    		-89,204,000 -100,915,000 -38,139,000 -122,159,000 -55,334,000 14,512,000 39,998,000 1,400,000 -15,438,000 9,009,000 3,820,000 -35,362,000 -431,000 -8,527,000 -27,133,000 13,660,000 1,702,000 117,035,000 -17,485,000 -204,481,000 29,664,000 59,911,000 -12,508,000 -87,872,000 -15,343,000 26,449,000 4,269,000 1,686,000 6,703,000 21,459,000 -10,472,000 6,233,000 -658,000 -29,696,000 -66,345,000 
      cash flows from financing activities
    		                                   
      payment of svb term loan and termination costs
    		   0 0 0 -37,751,000                             
      proceeds from braidwell debt
    		   0 0 0 75,000,000                             
      payments of issuance costs for braidwell debt
    		   0 0 -297,000 -1,803,000                             
      payment of braidwell debt and termination costs
    		   0 0 0 -78,660,000                             
      proceeds from issuance of 2029 notes
    		   0 0 0 661,250,000                             
      payments of issuance costs for 2029 notes
    		   0 -183,000 -649,000 -16,592,000                             
      purchases of capped call transactions
    		   0 0 0 -72,407,000                             
      purchase of treasury stock
    		   0 0 0 -25,000,000                             
      proceeds from issuance of common stock in connection with employee equity incentive plans
    		825,000 7,094,000 1,729,000 2,987,000 148,000 4,734,000 604,000 3,468,000 66,000 4,381,000 905,000 1,662,000 7,296,000 1,076,000 3,286,000 80,000 4,001,000 1,576,000 6,562,000                 
      net cash from financing activities
    		825,000 7,094,000 1,729,000 2,987,000 -35,000 3,788,000 504,641,000 3,468,000 66,000 4,381,000 905,000 1,662,000 7,270,000 14,636,000 369,000 -2,838,000 338,000 -26,446,000 2,959,000 207,145,000 5,705,000 -1,493,000 3,196,000 106,574,000 2,944,000 -1,138,000 2,757,000 1,515,000 2,428,000 -397,000 2,437,000 1,735,000 2,325,000 35,000 113,261,000 
      effect of exchange rate changes
    		-4,000 -11,000 -18,000     -201,000 76,000                           
      net increase in cash, cash equivalents and restricted cash
    		-53,500,000 -66,173,000 -44,319,000                                 
      cash, cash equivalents and restricted cash, beginning of period
    		0 0 427,955,000                                 
      cash, cash equivalents and restricted cash, end of period
    		-53,500,000 -66,173,000 383,636,000                                 
      sales of marketable securities
    		                                   
      purchase of acquired in-process research and development
    		                                   
      proceeds from svb term loan
    		                                   
      net increase in cash and cash equivalents
    		           -30,031,000 6,467,000 -32,776,000 -39,809,000 28,499,000 1,497,000 48,747,000 -6,708,000 13,606,000 25,216,000 36,052,000 -14,172,000    2,678,000 -1,896,000 2,768,000 7,802,000      
      cash and cash equivalents, beginning of year
    		                                   
      cash and cash equivalents, end of year
    		                                   
      effect of exchange rate changes on cash
    		    5,000 -9,000 -4,000                             
      net increase in cash, cash equivalents, and restricted cash
    		    -31,017,000 30,131,000 492,606,000                  -12,081,000 8,212,000          
      cash, cash equivalents, and restricted cash, beginning of period
    		    0 0 36,173,000                             
      cash, cash equivalents, and restricted cash, end of period
    		    -31,017,000 30,131,000 528,779,000                             
      supplemental disclosures of cash flow information:
    		                                   
      interest paid
    		     0 1,595,000 774,000 769,000 739,000 678,000 462,000 247,000 1,967,000 251,000 285,000 327,000 331,000 370,000 336,000 402,000 394,000 398,000 410,000 425,000 411,000 3,513,000 804,000 961,000 787,000 398,000 777,000 0 375,000 378,000 
      cash taxes paid
    		     349,000 11,000 336,000 506,000 280,000 8,000                         
      cash received from tenant improvement allowances
    		       0 0 0 1,603,000                         
      non-cash investing and financing activities:
    		                                   
      property and equipment costs included in accounts payable and accrued liabilities
    		     210,000 23,000    203,000   225,000  -5,283,000 5,204,000 115,000  -1,322,000 1,233,000 136,000              
      capitalized stock-based compensation in property and equipment
    		     2,180,000 1,649,000 1,787,000 1,820,000                           
      benefit from doubtful accounts and contractual allowances
    		      16,289,000 17,973,000 14,169,000 16,061,000 21,425,000 14,529,000 15,227,000 14,022,000  9,755,000 4,412,000 9,768,000  6,927,000 4,340,000 9,184,000  6,898,000 5,974,000 4,709,000  2,481,000 3,760,000 2,680,000      
      accounts payable
    		       -1,668,000 62,000 -2,629,000 2,262,000 1,417,000 786,000 -5,308,000 5,643,000 -1,381,000 1,200,000 673,000 819,000 -160,000 -1,705,000 -2,835,000 5,723,000 -1,144,000 1,358,000 -333,000 332,000 -630,000 1,056,000 -950,000 667,000 -559,000 1,216,000 -690,000 236,000 
      accrued liabilities
    		       8,388,000 12,180,000 9,958,000 -11,228,000 9,348,000 8,153,000 -9,429,000 -3,392,000 13,323,000 4,155,000 -6,140,000 6,673,000 4,324,000 -222,000 -9,467,000 367,000 8,822,000 3,193,000 -6,380,000 7,441,000 2,838,000 3,474,000 -2,977,000 4,070,000 1,075,000 2,092,000 -1,873,000 3,743,000 
      purchase of strategic investment
    		       0 0                           
      payment of loans
    		                                   
      proceeds from term loans
    		                                   
      tax withholding upon vesting of restricted stock awards
    		              0 -1,000 -747,000 -25,105,000 -1,297,000 -3,563,000 -687,000 -4,462,000 -177,000 -1,554,000 -299,000 -3,258,000 -2,239,000 -100,000 -264,000 -1,274,000      
      payment of issuance costs for long-term debt
    		                                   
      right-of-use assets obtained in exchange for operating lease liabilities
    		       -117,000    0 0 7,666,000                      
      proceeds from term loan
    		           0 0 35,000,000                      
      payments of issuance costs for long-term debt
    		                                   
      net decrease in cash and cash equivalents
    		        -14,100,000 8,774,000 -26,028,000                     4,180,000 666,000 -36,060,000  
      cash and cash equivalents, beginning of period
    		        0 0 78,832,000                     0 0 51,643,000  
      cash and cash equivalents, end of period
    		        -14,100,000 8,774,000 52,804,000                     4,180,000 666,000 15,583,000  
      property and equipment included in accounts payable and accrued liabilities
    		        -18,000                           
      amortization of premium and accretion of discounts on investments
    		          -1,137,000                         
      purchases of short-term investments
    		          -33,757,000                         
      sales of short-term investments
    		                                   
      maturities of short-term investments
    		          46,000,000                         
      capitalized stock-based compensation
    		          1,648,000 1,524,000 1,532,000 1,250,000 1,059,000 902,000 721,000 911,000                  
      accretion of discounts on investments
    		           -147,000             -192,000 -227,000          
      reimbursement of tenant improvement allowance
    		               0                    
      payment of long-term debt
    		           0 0 -21,389,000                      
      payments of issuance costs for long term debt
    		           0 -26,000 -51,000                      
      cash and cash equivalents beginning of period
    		           0 0 127,562,000  0 0 88,628,000  0 0 20,462,000              
      cash and cash equivalents end of period
    		           -30,031,000 6,467,000 94,786,000  28,499,000 1,497,000 137,375,000  13,606,000 25,216,000 56,514,000              
      supplemental disclosures of cash flow information
    		                                   
      non-cash investing and financing activities
    		                                   
      purchases of available-for-sale investments
    		            -45,545,000 -45,974,000 -55,508,000 -20,247,000 -16,375,000 -30,054,000 -62,621,000 -206,880,000 0 -8,009,000 -19,889,000 -101,050,000 -35,360,000 -9,616,000 -19,088,000 -31,454,000 -37,179,000 -5,437,000 -39,586,000 -34,209,000 -24,212,000 -31,822,000  
      sales of available-for-sale investments
    		            19,946,000 15,019,000     0 0 0 14,525,000              
      maturities of available-for-sale investments
    		            36,000,000 28,000,000 33,000,000 47,215,000 24,000,000 151,300,000 47,500,000 8,000,000 31,845,000 56,800,000 17,700,000 17,350,000 22,850,000 37,700,000 18,888,000 34,601,000 45,000,000 28,004,000 30,025,000 40,882,000 24,500,000 3,300,000  
      accretion of discounts on investments, net and other
    		             432,000  338,000 512,000 498,000  38,000                
      amortization of debt discount and issuance costs
    		                     4,000 4,000 2,000 5,000 26,000 92,000 -7,000 61,000 64,000 63,000 69,000 64,000 64,000 -33,000 
      accretion of discounts on investments, net of premium amortization
    		                     -171,000 -268,000             
      benefit from bad debt and contractual allowance
    		                              3,476,000 1,711,000    
      cost of operating lease right-of-use assets
    		                                   
      issuance of common stock in connection with follow-on public offering
    		                                   
      repayments of long-term debt
    		                                   
      deferred offering costs included in accounts payable and accrued liabilities
    		                                   
      right-of-use assets obtained in exchange for new operating lease liabilities
    		                290,000 5,757,000 0 0 0 621,000 -310,000             
      issuance of common stock in follow-on public offering, net of offering costs
    		                                   
      offering costs included in accounts payable and accrued liabilities
    		                                   
      payment of long term debt
    		                -2,916,000 -2,917,000                  
      loss on disposal of assets
    		                          4,000         
      repayment of interest paid in kind
    		                                   
      deferred rent
    		                          52,000 -8,000 -5,000 66,000 -8,000 29,000   -1,000 
      proceeds from long-term debt, net of debt discount
    		                                   
      premiums paid on extinguishment of debt
    		                                   
      issuance of common stock in connection with follow-on public offering, net of offering costs
    		                                   
      offering costs in accounts payable and accrued liabilities
    		                                   
      proceeds from issuance of common stock
    		                    6,392,000 2,969,000 3,086,000 1,000,000 3,289,000 2,120,000  1,615,000 4,192,000 877,000      
      non-cash interest expense
    		                              398,000 393,000 384,000 375,000 382,000 
      payments of deferred offering costs
    		                                   
      issuance of common stock in public offering
    		                                   
      repayment of debt
    		                           0        
      stock offering costs included in accounts payable and accrued liabilities
    		                                   
      cash, cash equivalents and restricted cash beginning of period
    		                        0 20,023,000  0 0 8,671,000      
      cash, cash equivalents and restricted cash end of period
    		                        -12,081,000 28,235,000  -1,896,000 2,768,000 16,473,000      
      property, plant and equipment costs included in liabilities
    		                                   
      property, plant and equipment costs included in accounts payable and accrued liabilities
    		                         38,000  -132,000        
      amortization (accretion) on investments
    		                                   
      change in fair value of preferred stock warrant liabilities
    		                                  1,127,000 
      proceeds from issuance of common stock upon exercise of stock options, net of repurchases
    		                                 35,000 50,000 
      proceeds from issuance of common stock upon exercise of warrants
    		                                   
      proceeds from long-term debt, net of debt discount and issuance costs
    		                                   
      proceeds of issuance of common stock upon initial public offering
    		                                   
      conversion of preferred stock to common stock
    		                                   
      conversion of preferred stock warrants to common stock warrants
    		                                   
      amortization of premiums (accretion of discounts) on investments
    		                           -283,000 -179,000 -171,000  -91,000 -70,000 -46,000  
      property, plant and equipment costs included in accounts payable
    		                             80,000  -22,000    
      change in accrued interest
    		                                   
      restricted cash
    		                                   
      proceeds from issuance of convertible preferred stock, net of issuance costs
    		                                   
      payments of issuance costs for revolving line of credit
    		                                   
      issuance of warrants to purchase preferred stock
    		                                   
      series e convertible preferred stock issuance costs included in accrued liabilities
    		                                   
      property and equipment included in accounts payable
    		                                  271,000 
      change in restricted cash
    		                                   
      net proceeds from employee stock transactions
    		                                   
      payments of deferred issuance costs
    		                                   
      proceeds from issuance of common stock related to the exercise of options and employee stock purchase program, net of repurchases
    		                                   
      change in allowance for doubtful accounts and contractual allowance
    		                                 1,772,000  
      series e preferred stock issuance costs included in accrued liabilities
    		                                   
      deferred offering costs included in accounts payables and accrued liabilities
    		                                   
      
    		                                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.